Skip to main content

Table 3 Levels of miR-17-3p, CEA, and CA19.9 in studied population (patients and control)

From: Role of circulating miRNA-17-3P as a potential diagnostic biomarker for sporadic colon cancer in Egyptian cohort

miRNA

Patients (n = 50)

Control (n = 25)

U

p

Min.–max.

1.74–32.45

0.27–3.41

5.00*

> 0.001*

Mean ± SD

9.07 ± 7.25

0.95 ± 0.63

Median

6.85

0.88

CEA

 Min.–max.

0.10–110.0

0.10–14.0

465.50

0.073

 Mean ± SD

8.63 ± 20.83

2.94 ± 3.24

 Median

2.90

2.20

CA19.9

 Min.–max.

0.25–700.0

5.0–30.0

302.50*

< 0.001*

 Mean ± SD

39.40 ± 97.61

9.56 ± 5.20

 Median

20.45

8.0